Ledger.Open graph →

SEC Form D · filed March 18, 2024

Kanvas Biosciences, Inc

Offering

$10.0M

Sold

$3.9M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

MONMOUTH JUNCTION, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Hao Shi · Monmouth Junction, NJExec · Director Matthew Cheng · Monmouth Junction, NJExec · Director Jason Pontin · Monmouth Junction, NJDirector Suhrid Mantravadi · Dallas, TXExec · Director John Howard · Dallas, TXDirector Daorong Huang · Roslyn, NYExec · Director Paul Theunissen · Monmouth Junction, NJDirector Vijay S. Pelaprolu · Plano, TXDirector Sambasiva R. Jastipoorna · Plano, TXExec · Director Benjamin C. Taylor · Nicholasville, KYExec · Director Paul Theunissen · Monmouth Junction, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗